Androgenetic alopecia Management Laboratory evaluation Q Does the patient have female pattern hair loss? Yes Obtain targeted endocrine evaluation (testosterone, DHEAS, and prolactin levels) in female patients presenting with hair loss associated with abnormal menses, history of infertility, hirsutism, unresponsive cystic acne, virilization, or galactorrhea. No Other topical therapies Offer topical adenosine in patients with male-pattern hair loss. B Consider offering topical adenosine in patients with female-pattern hair loss. C Consider offering topical carpronium chloride, t-flavanone, cytopurine, pentadecane, and ketoconazole in patients with pattern hair loss. C 5-alpha-reductase inhibitors, female-pattern hair loss Do not use oral finasteride or dutasteride in patients with female-pattern hair loss. D Self-hair transplantation, female-pattern hair loss Consider offering self-hair transplantation in patients with female-pattern hair loss. C Laser therapy Offer irradiation with LED and low-level lasers in patients with pattern hair loss. B Prosthetic hair transplantation Do not offer prosthetic hair transplantation in patients with pattern hair loss. D Therapies with no evidence for benefit Do not offer the following therapies in patients with pattern hair loss: bimatoprost latanoprost growth factors cell transplantation therapy. D Use of wigs Consider advising the use of wigs as an option for hair loss. C